Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FKJH4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,397
Award facts
- Contract value 100% obligated
- $12,396.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 5mg. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, and no set-aside designation was utilized. DMS Pharmaceutical Group competes in the open market based on its competitive capabilities and established performance record serving military healthcare facilities. The delivery will be performed in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $500 million ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents part of the broader $30.3 billion Department of Defense pharmaceutical supply chain modernization effort, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to supply a comprehensive range of branded and generic prescription drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. The company's established track record across multiple therapeutic categories demonstrates its capability to fulfill specialized pharmaceutical requirements for military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FKJH4?
SPE2DR26FKJH4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FKJH4 worth?
The government has obligated $12,397 on SPE2DR26FKJH4.
Is contract SPE2DR26FKJH4 an order under another contract?
Yes. SPE2DR26FKJH4 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJH4 competed?
The extent of competition for SPE2DR26FKJH4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award